Firefly Neuroscience, Inc. Cash Flow Conversion Efficiency
Firefly Neuroscience, Inc. cash flow conversion efficiency. Based on the latest financial reports, Firefly Neuroscience, Inc. (AIFF) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.49 Million) by net assets ($9.66 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Firefly Neuroscience, Inc. (2020–2024)
Cash flow conversion efficiency of Firefly Neuroscience, Inc. from 2020 to 2024. This chart illustrates how Firefly Neuroscience, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Firefly Neuroscience, Inc. stock price today for real-time trading data and today's change.
Firefly Neuroscience, Inc. Cash Flow Conversion Ratio Explained
Firefly Neuroscience, Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Firefly Neuroscience, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Firefly Neuroscience, Inc. ranked by their cash flow conversion efficiency. Also see Firefly Neuroscience, Inc. market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eagle Plains Resources Ltd.
V:EPL
|
0.053x |
|
Pardus Girisim Sermayesi Yatirim Ortakligi A.S.
IS:PRDGS
|
0.024x |
|
Group One Capital Limited
AU:G1C
|
0.084x |
|
Tarmat Limited
NSE:TARMAT
|
0.016x |
|
MyTech Group Bhd
KLSE:7692
|
0.134x |
|
JPMorgan Japanese Investment Trust
LSE:JFJ
|
0.001x |
|
Ecocab Co. Ltd
KQ:128540
|
0.095x |
|
Aegis Brands Inc
TO:AEG
|
0.013x |
Annual Cash Flow Conversion Efficiency for Firefly Neuroscience, Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Firefly Neuroscience, Inc. from 2020 to 2024. Review AIFF cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-375.00K | $-6.16 Million | 16.413x | +182.37% |
| 2023-12-31 | $109.00K | $-2.17 Million | -19.927x | -1554.53% |
| 2022-12-31 | $-2.11 Million | $-2.89 Million | 1.370x | +8.09% |
| 2021-12-31 | $-3.01 Million | $-3.82 Million | 1.267x | +383.11% |
| 2020-12-31 | $1.61 Million | $423.26K | 0.262x | -- |
About Firefly Neuroscience, Inc.
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depres… Read more